Dr. Daniel Armstrong Named Co-Director of CTSI’s Integrating Special Populations
The Miami CTSI welcomes Daniel Armstrong, Ph.D., as the Co-Director of its Integrating Special Populations (ISP) Program. Dr. Armstrong will join David Loewenstein, Ph.D., in leading the program, which aims to promote participation of diverse populations across the lifespan in research.
Dr. Armstrong is Professor of Pediatrics and Psychology, Executive Vice Chair in the Department of Pediatrics, Director of the Mailman Center for Child Development and Senior Associate Dean for Child Health at the Miller School of Medicine.
Dr. Armstrong has been representing the Miami CTSI in the CTSA consortium Lifespan Working Group for many years. The group’s paper “Charting the Life Course: Emerging Opportunities to Advance Scientific Approaches Using Life Course Research,” was recently accepted for publication in the Journal of Clinical and Translational Science.
He also co-directed the Master of Science in Clinical and Translational Investigation (MSCTI) Program for two years during the CTSI’s first award cycle.
Over the past 35 years he has served in multiple senior clinical, research, educational (LCME, GME, graduate, and research training), and administrative leadership roles in the Department of Pediatrics and Miller School of Medicine.
Throughout his career, Dr. Armstrong’s research has focused on describing neurodevelopmental outcomes of treatment of childhood cancer, sickle cell disease, and HIV/AIDS, understanding the mechanisms associated with these outcomes, and conducting clinical trials of interventions (behavioral, biological, and pharmacological) with children with neurodevelopmental disabilities and chronic illnesses. Most of his research has involved interdisciplinary and multi-center collaboration.
Former ISP Co-Director Gwendolyn Scott, M.D. will continue to lead the CTSI KL2 Program as its Multi-PI and Co-Director.